These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20938089)

  • 1. Antibodies in cancer immunotherapy.
    Karyampudi L; Knutson KL
    Cancer Biomark; 2010; 6(5-6):291-305. PubMed ID: 20938089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-specific antibodies for cancer immunotherapy.
    Jachimowicz RD; Borchmann S; Rothe A
    BioDrugs; 2014 Aug; 28(4):331-43. PubMed ID: 24638872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From a Patient Advocate's Perspective: Does Cancer Immunotherapy Represent a Paradigm Shift?
    Madden DL
    Curr Oncol Rep; 2018 Feb; 20(1):8. PubMed ID: 29411148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and Antibody Based Approaches for Pediatric Cancer Immunotherapy.
    Huang MA; Krishnadas DK; Lucas KG
    J Immunol Res; 2015; 2015():675269. PubMed ID: 26587548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies as therapeutics in oncology.
    Trikha M; Yan L; Nakada MT
    Curr Opin Biotechnol; 2002 Dec; 13(6):609-14. PubMed ID: 12482522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MUC1 antibody-based therapeutics: the promise of cancer immunotherapy.
    Pourjafar M; Samadi P; Saidijam M
    Immunotherapy; 2020 Dec; 12(17):1269-1286. PubMed ID: 33019839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on Mucin-1 immunotherapy in cancer: a clinical perspective.
    Rivalland G; Loveland B; Mitchell P
    Expert Opin Biol Ther; 2015; 15(12):1773-87. PubMed ID: 26453294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tumor monoclonal antibodies in conjunction with β-glucans: a novel anti-cancer immunotherapy.
    Xiang D; Sharma VR; Freter CE; Yan J
    Curr Med Chem; 2012; 19(25):4298-305. PubMed ID: 22834812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Antibodies in Cancer Therapy.
    Gasser M; Waaga-Gasser AM
    Adv Exp Med Biol; 2016; 917():95-120. PubMed ID: 27236554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel antibodies targeting immune regulatory checkpoints for cancer therapy.
    Lee CS; Cragg M; Glennie M; Johnson P
    Br J Clin Pharmacol; 2013 Aug; 76(2):233-47. PubMed ID: 23701301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New trends in epidermal growth factor receptor-directed monoclonal antibodies.
    Markman B; Capdevila J; Elez E; Tabernero J
    Immunotherapy; 2009 Nov; 1(6):965-82. PubMed ID: 20635913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies in cancer immunotherapy.
    Kimiz-Gebologlu I; Gulce-Iz S; Biray-Avci C
    Mol Biol Rep; 2018 Dec; 45(6):2935-2940. PubMed ID: 30311129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in strategies and methodologies in cancer immunotherapy.
    Lam SS; Zhou F; Hode T; Nordquist RE; Alleruzzo L; Raker J; Chen WR
    Discov Med; 2015 Apr; 19(105):293-301. PubMed ID: 25977192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies in solid tumours: approaches to therapy with emphasis on gynaecological cancer.
    Fleckenstein G; Osmers R; Puchta J
    Med Oncol; 1998 Dec; 15(4):212-21. PubMed ID: 9951683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual antibody therapy to harness the innate anti-tumor immune response to enhance antibody targeting of tumors.
    Chester C; Marabelle A; Houot R; Kohrt HE
    Curr Opin Immunol; 2015 Apr; 33():1-8. PubMed ID: 25576932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy as an Option for Cancer Treatment.
    Rusch T; Bayry J; Werner J; Shevchenko I; Bazhin AV
    Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):89-96. PubMed ID: 29026920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically engineered monoclonal antibodies for direct anti-neoplastic treatment and cancer cell specific delivery of chemotherapeutic agents.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Curr Pharm Des; 2000 Feb; 6(3):261-76. PubMed ID: 10637379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are mimotope vaccines a good alternative to monoclonal antibodies?
    Pourjafar M; Samadi P; Khoshinani HM; Saidijam M
    Immunotherapy; 2019 Jun; 11(9):795-800. PubMed ID: 31094256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy-based combinations: current status and perspectives.
    de Miguel-Luken MJ; Mansinho A; Boni V; Calvo E
    Curr Opin Oncol; 2017 Sep; 29(5):382-394. PubMed ID: 28678031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.